×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
作者
石磊 [2]
发表日期
2022 [3]
2021 [3]
2020 [4]
语种
英语 [10]
出处
FRONTIERS ... [3]
TRANSLATIO... [2]
BMC CANCER [1]
EUROPEAN J... [1]
MOLECULAR ... [1]
ONCOTARGET... [1]
更多...
资助项目
National N... [2]
National N... [2]
National N... [2]
AME Lung C... [1]
Key R&D Pr... [1]
National N... [1]
更多...
资助机构
National ... [10]
Natural Sc... [3]
AME Lung C... [1]
Key R&D Pr... [1]
Projects o... [1]
Science an... [1]
更多...
收录类别
SCI [10]
摘要
文献类型
期刊论文 [10]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
限定条件
资助机构:National Natural Science Foundation of China
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
WOS被引频次升序
WOS被引频次降序
题名升序
题名降序
作者升序
作者降序
期刊影响因子升序
期刊影响因子降序
Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Xu, Yuan-rui
;
Wang, An-long
;
Li, Ya-qing
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2022/12/23
chronic obstructive pulmonary disease
lung cancer
non-small cell lung cancer
hypoxia-inducible factor 1-alpha
hypoxia-inducible factor 1
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
;
Yu, Xinmin
;
Chen, Ming
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:
Xu, Xiaoling
;
Shen, Wenming
;
Wang, Ding
;
Li, Na
;
Huang, Zhiyu
;
Sheng, Jiamin
;
Rucker, A. Justin
;
Mao, Weimin
;
Xu, Haimiao
;
Cheng, Guoping
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2022/05/05
Non-small cell lung cancer (NSCLC)
pulmonary invasive mucinous adenocarcinoma
propensity-matched analysis
prognosis
Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
期刊论文
MOLECULAR BRAIN, 2021, 卷号: 14
作者:
Xu, Yanjun
;
Huang, Zhiyu
;
Yu, Xiaoqing
;
Chen, Kaiyan
;
Fan, Yun
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2022/01/25
Brain metastases
Predictive biomarker
DNA methylation
Somatic mutation
Advanced non-small cell lung cancer (advanced NSCLC)
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2021
作者:
Xu, Xiaoling
;
Wang, Ding
;
Chen, Wei
;
Li, Na
;
Suwinski, Rafal
;
Rossi, Antonio
;
Rosell, Rafael
;
Zhong, Jianxiang
;
Fan, Yun
收藏
  |  
浏览/下载:76/0
  |  
提交时间:2022/02/14
Immune checkpoint inhibitor (ICI)
non-small cell lung cancer (NSCLC)
peripheral blood lymphocyte subsets
High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10
作者:
Tong, Ying-Hui
;
Hu, Xiao-Ping
;
Xiang, Xue-Ping
;
Fang, Luo
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2021/05/17
Monocarboxylate transporter 1 (MCT1)
monocarboxylate transporter 4 (MCT4)
prognosis
non-small cell lung cancer (NSCLC)
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Wang, Wenxian
;
Huang, Zhangzhou
;
Yu, Zongyang
;
Zhuang, Wu
;
Zheng, Weijun
;
Cai, Zhijian
;
Shi, Lei
;
Yu, Xinmin
;
Lou, Guangyuan
;
Hong, Wei
;
Zhang, Yiping
;
Chen, Ming
;
Song, Zhengbo
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2020/11/30
immune checkpoint inhibitor
non-small cell lung cancer
biomarker
chemotherapy
lung immune prognostic index
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients
期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:
Song, Zhengbo
;
Liu, Tianchi
;
Shi, Lei
;
Yu, Zongyang
;
Shen, Qing
;
Xu, Mengdi
;
Huang, Zhangzhou
;
Cai, Zhijian
;
Wang, Wenxian
;
Xu, Chunwei
;
Sun, Jingjing
;
Chen, Ming
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2020/10/26
Deep learning model
Anaplastic lymphoma kinase
Computed tomography
Non-small cell lung cancer
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Lin, Chen
;
Shi, Xun
;
Zhao, Jun
;
He, Qiong
;
Fan, Yun
;
Xu, Weizhen
;
Shao, Yang
;
Yu, Xinmin
;
Jin, Ying
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2020/10/26
tumor mutation burden (TMB)
clinical benefit
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)
chemotherapy
non-small cell lung cancer (NSCLC)
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers
期刊论文
ONCOTARGETS AND THERAPY, 2020, 卷号: 13
作者:
Ma, De-Ning
;
Gao, Xin-Yi
;
Dan, Yi-Bo
;
Zhang, An-Ni
;
Wang, Wei-Jun
;
Yang, Guang
;
Zhu, Hong-Zhou
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2020/11/26
radiogenomics
SVM
non-small cell lung cancer
anaplastic lymphoma kinase
epidermal growth factor receptor